2015 American Transplant Congress
Post Hoc Subgroup Analysis of ZEUS: Outcome on Renal Function, Efficacy and Safety in Living-Donor Kidney Transplant Recipients After Conversion from a Calcineurin Inhibitor to an Everolimus Based Regimen: 5 Year Follow-Up Data
1ZEUS Study Group, Germany; 2ZEUS Study Group, Switzerland; 3Novartis, Pharma, Germany.
Background: To study renal function and patient outcome after 5 years in living donation subgroup of kidney de novo transplant recipients after conversion to an…2015 American Transplant Congress
Plasma Cell Infiltration: General Overview of Clinical and Pathological Correlations in Renal Transplantation
Transplantation Service, Hospital das Clinicas-University of São Paulo, São Paulo, SP, Brazil.
Background and Objective: Plasma cells are known as the final effectors of humoral immune response. Their significance and clinical outcomes are still controversial in kidney…2015 American Transplant Congress
Impact of Everolimus On the Hepatocellular Carcinoma Recurrence After Living Donor Liver Transplantation When Used in Early Stage: A Single Center Prospective Study
Organ Transplantation Center, China Medical University Hospital, Taichung, Taiwan.
Background:Liver transplantation is only treatment for unresectable hepatocellular carcinoma (HCC). However, postoperative immunosuppression may act as an additional risk factor for tumour recurrence. Antineoplastic role…2015 American Transplant Congress
Ethnic Barriers in Pediatric Liver Transplant Recipients. A Retrospective Study
INTRODUCTION: Differences in access to OLTx continue to be present in minorities. Pediatric pts represent a particularly vulnerable population within minorities groups in need for…2015 American Transplant Congress
Arterial Hypertension and the Use of Antihypertensive Medication in Pediatric Renal Transplant Patients: An Analysis of the CERTAIN Registry
BackgroundOur study aimed to describe the prevalence of hypertension, blood pressure (BP) control and the use of antihypertensive (AH) drugs in pediatric renal transplant patients.MethodsCasual…2015 American Transplant Congress
The Effects of Dialysis Vintage and Hypertensive Renal Failure on Colonoscopy Findings During Kidney Transplant Evaluation
Colonoscopy as a screening modality starting at age 50 has recently undergone scrutiny due to concerns over the risks and benefits. We sought to identify…2015 American Transplant Congress
Is There a Protective Value for Low Level Donor Specific Antibodies to Prevent Cardiac Allograft Vasculopathy After Heart Transplant?
Cedars-Sinai Heart Institute, Los Angeles, CA.
Purpose: Donor specific antibodies (DSA) following heart transplant has been reported to be associated with increased development of cardiac allograft vasculopathy (CAV) and risk of…2015 American Transplant Congress
Recurrent Cytomegalovirus Infection After Solid Organ Transplant
University Health Network, Toronto, Canada.
Background:Cytomegalovirus is a common opportunistic infection after transplant. Relapse may occur after treatment of the initial episode of viremia or disease and secondary prophylaxis is…2015 American Transplant Congress
Increased Frequency of Terminally Differentiated and Exhausted CD8+ T Cells Is Associated With Adverse Clinical Outcome After Mechanical Circulatory Support Device Implantation
Clinical outcomes vary after mechanical circulatory support device (MCSD) implantation, with some patients developing multi organ system dysfunction (MOD), sometimes leading to death. We hypothesized…2015 American Transplant Congress
Long-term Patient and Graft Survival After Kidney Transplantation in Recipients With Hepatitis C Virus Infection
Division of Gastroenterology and Hepatology, Stanford University, Stanford.
Background: The prevalence of hepatitis C virus (HCV) infection among kidney transplant (KTx) recipients is higher than that in the general population. With the advent…
American Transplant Congress abstracts